Pallone did not favor a permanent extension of the rare pediatric priority review voucher program in part because of the strain it puts on the FDA. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
